$93.36-2.71 (-2.82%)
HealthEquity, Inc.
HealthEquity, Inc. in the Healthcare sector is trading at $93.36 with a market capitalization of $7.2B. Wall Street consensus targets $119.00 (15 analysts), implying a +27.5% move over the next 12 months. The stock is currently 13% below its 52-week high of $107.62, remaining 4.5% above its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $354.64M↑ | $334.59M↑ | $322.16M↓ | $325.83M↓ | $330.84M |
| Gross Profit | $256.31M↑ | $228.15M | $228.06M↓ | $232.59M↑ | $224.31M |
| Operating Income | $104.07M↑ | $72.39M↓ | $79.85M↓ | $90.88M↑ | $84.35M |
| Net Income | $69.42M↑ | $49.74M↓ | $51.69M↓ | $59.85M↑ | $53.91M |
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web...

HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.

HealthEquity's 15.7% three-month rally is backed by rising HSA scale, stronger margins and higher guidance, though key risks remain.

HealthEquity (NASDAQ:HQY) posted second-quarter fiscal 2027 results on August 27, which pushed revenue growth to 8% year over year, up from the 7% pace set over the first half of the year, a rare acceleration for a company already sitting on 10.7 million health savings accounts/HSAs. Adjusted EBITDA jumped 11% to $167 million, translating into […]

Record profitability and accelerated invested asset growth signal durability.

Sales and earnings beats in fiscal Q2 weren't enough to satisfy investors.